loading
前日終値:
$3.62
開ける:
$3.59
24時間の取引高:
1.12M
Relative Volume:
0.73
時価総額:
$576.69M
収益:
$361.51M
当期純損益:
$102.18M
株価収益率:
5.842
EPS:
0.5974
ネットキャッシュフロー:
$112.21M
1週間 パフォーマンス:
+0.87%
1か月 パフォーマンス:
-12.09%
6か月 パフォーマンス:
-15.39%
1年 パフォーマンス:
+132.67%
1日の値動き範囲:
Value
$3.45
$3.64
1週間の範囲:
Value
$3.45
$3.695
52週間の値動き範囲:
Value
$1.4705
$5.78

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
名前
Ironwood Pharmaceuticals Inc
Name
セクター
Healthcare (1052)
Name
電話
617-621-7722
Name
住所
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
職員
100
Name
Twitter
@ironwoodpharma
Name
次回の収益日
2026-11-09
Name
最新のSEC提出書
Name
IRWD's Discussions on Twitter

Compare IRWD vs TAK, TEVA, HLN, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
IRWD icon
IRWD
Ironwood Pharmaceuticals Inc
3.49 576.69M 361.51M 102.18M 112.21M 0.5974
TAK icon
TAK
Takeda Pharmaceutical Co Adr
20.93 66.87B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
42.02 49.01B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
8.655 38.06B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
79.64 32.91B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
597.84 25.64B 3.17B 1.29B 1.01B 27.09

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-05 アップグレード Citizens JMP Mkt Perform → Mkt Outperform
2025-04-15 ダウングレード Jefferies Buy → Hold
2025-04-15 ダウングレード Wells Fargo Overweight → Equal Weight
2025-04-14 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 開始されました Leerink Partners Market Perform
2024-08-08 ダウングレード CapitalOne Overweight → Equal Weight
2024-01-17 開始されました Craig Hallum Buy
2023-12-14 開始されました Wells Fargo Overweight
2023-11-09 開始されました Jefferies Buy
2023-09-28 開始されました JMP Securities Mkt Outperform
2022-09-02 開始されました CapitalOne Overweight
2022-04-22 開始されました Piper Sandler Overweight
2020-09-30 ダウングレード Wells Fargo Overweight → Equal Weight
2020-06-17 開始されました Northland Capital Outperform
2019-07-10 再開されました Credit Suisse Neutral
2019-03-27 アップグレード Morgan Stanley Underweight → Equal-Weight
2019-02-25 アップグレード H.C. Wainwright Sell → Neutral
2019-01-24 アップグレード JP Morgan Underweight → Neutral
2018-11-07 ダウングレード Credit Suisse Outperform → Neutral
2018-11-07 ダウングレード JP Morgan Neutral → Underweight
2018-07-23 開始されました H.C. Wainwright Sell
2018-05-09 ダウングレード Morgan Stanley Equal-Weight → Underweight
2018-01-05 ダウングレード BofA/Merrill Buy → Underperform
2017-12-06 ダウングレード Mizuho Buy → Neutral
2017-07-21 ダウングレード JP Morgan Overweight → Neutral
2017-05-03 開始されました Wells Fargo Outperform
2017-04-07 繰り返されました Mizuho Buy
2017-02-22 繰り返されました Barclays Equal Weight
2016-11-04 繰り返されました Mizuho Buy
2016-10-24 繰り返されました Wedbush Neutral
2016-10-10 繰り返されました Mizuho Buy
2016-09-27 繰り返されました WallachBeth Hold
すべてを表示

Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース

pulisher
Oct 28, 2026

Bank of America reports an Ironwood Pharmaceuticals (IRWD) stake with no sole voting power. - Stock Titan

Oct 28, 2026
pulisher
Oct 23, 2026

Ironwood Pharmaceuticals, Inc. Estimates – NASDAQ:IRWD - TradingView

Oct 23, 2026
pulisher
Oct 16, 2026

Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer - BioSpace

Oct 16, 2026
pulisher
Oct 16, 2026

Ironwood Pharmaceuticals Appoints Tammi Gaskins as CEO Effective January 2027 - Kalkine Media

Oct 16, 2026
pulisher
Oct 16, 2026

Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer - Business Wire

Oct 16, 2026
pulisher
Oct 07, 2026

Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3? - Zacks Investment Research

Oct 07, 2026
pulisher
Sep 30, 2026

PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? - Zacks Investment Research

Sep 30, 2026
pulisher
Sep 27, 2026

Form 144 IRONWOOD PHARMACEUTICALS INC For: 27 September By Investing.com - Investing.com Australia

Sep 27, 2026
pulisher
Sep 27, 2026

Form 144 IRONWOOD PHARMACEUTICALS INC For: 27 September By Investing.com - Investing.com Nigeria

Sep 27, 2026
pulisher
Sep 27, 2026

Form 144 IRONWOOD PHARMACEUTICALS INC For: 27 September By Investing.com - Investing.com India

Sep 27, 2026
pulisher
Sep 23, 2026

83,306 shares to cover taxes: Ironwood Pharmaceuticals (IRWD) ex-officer proposes a sale - Stock Titan

Sep 23, 2026
pulisher
Sep 17, 2026

Ironwood Pharmaceuticals Director Alexander J. Denner Awarded 3,694 Shares Under Compensation Policy - Kalkine Media

Sep 17, 2026
pulisher
Sep 11, 2026

Ironwood: Medicare Is Not The Problem I Thought It Was - Seeking Alpha

Sep 11, 2026
pulisher
Sep 10, 2026

Ironwood Pharmaceuticals at Wells Fargo conference: linzess rebound drives turnaround - Investing.com Canada

Sep 10, 2026
pulisher
Sep 10, 2026

Ironwood Pharmaceuticals at Wells Fargo conference: linzess rebound drives turnaround - Investing.com UK

Sep 10, 2026
pulisher
Sep 09, 2026

IRWD Stock Price, Quote & News - Syfe

Sep 09, 2026
pulisher
Sep 04, 2026

IRWD stock gains as Wells Fargo conference spotlight shifts to cash flow - ad-hoc-news.de

Sep 04, 2026
pulisher
Sep 03, 2026

Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference - Yahoo Finance

Sep 03, 2026
pulisher
Aug 30, 2026

Ironwood Pharmaceuticals Inc. Class A (IRWD) Peer Comparison – Compare with Others - Value Research

Aug 30, 2026
pulisher
Aug 30, 2026

Ironwood Pharmaceuticals (IRWD) Slips 2.6% as Shares Approach Key Support at $3.92Backspread Trade - vinanet.vn

Aug 30, 2026
pulisher
Aug 30, 2026

Ironwood Pharmaceuticals (IRWD) Slips 2.59% to $4.13: Analyzing Key Support and Resistance LevelsETF Flow - dars.gov.et

Aug 30, 2026
pulisher
Aug 28, 2026

Ironwood Pharmaceuticals Inc. Class A (IRWD) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026
pulisher
Aug 26, 2026

Ironwood Pharmaceuticals: High Dependence On Its Next Trial (NASDAQ:IRWD) - Seeking Alpha

Aug 26, 2026
pulisher
Aug 20, 2026

Ironwood (IRWD) Results Versus Estimates: EPS Does Not Reach the Reported Estimate for the Current Session; Market Move: The Market Price Moves 1.16% Higher in Latest TradingEarnings Yield Analysis - vinanet.vn

Aug 20, 2026
pulisher
Aug 17, 2026

Ironwood Pharmaceuticals (IRWD) Edges Higher: Shares Advance 1.16% as Bulls Defend Key SupportRSI Oversold Picks - vinanet.vn

Aug 17, 2026
pulisher
Aug 17, 2026

Ironwood Pharmaceuticals (IRWD) Edges Higher: Shares Advance 1.16% as Bulls Defend Key SupportValue ETF - dars.gov.et

Aug 17, 2026
pulisher
Aug 16, 2026

Jeffrey Silber Net Worth (2026) - GuruFocus

Aug 16, 2026
pulisher
Aug 16, 2026

Bank of America Corp DE Sells 2,838,753 Shares of Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 16, 2026
pulisher
Aug 15, 2026

Ironwood Pharmaceuticals | ARS: Annual Report to Security Holders - Moomoo

Aug 15, 2026
pulisher
Aug 15, 2026

Ironwood Pharmaceuticals (IRWD) Q2 2026 Earnings: EPS Misses Estimates, Stock Climbs 5.64%Dividend Growth Analysis - vinanet.vn

Aug 15, 2026
pulisher
Aug 14, 2026

Armistice Capital (IRWD) discloses 13.9M-share Ironwood Pharmaceuticals stake - stocktitan.net

Aug 14, 2026
pulisher
Aug 11, 2026

Dimensional Fund Advisors LP Raises Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 11, 2026
pulisher
Aug 10, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap DownTime to Sell? - MarketBeat

Aug 10, 2026
pulisher
Aug 08, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

Aug 08, 2026
pulisher
Aug 08, 2026

Ironwood Pharmaceuticals, Inc. $IRWD Shares Sold by Amundi - MarketBeat

Aug 08, 2026
pulisher
Aug 08, 2026

Ironwood Pharmaceuticals (NASDAQ:IRWD) Downgraded to Buy Rating by Wall Street Zen - MarketBeat

Aug 08, 2026
pulisher
Aug 07, 2026

State Street Corporation (NYSE: IRWD caretaker) holds 5.4% of Ironwood common stock - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

Ironwood Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

Pacer Advisors Inc. Makes New $3.98 Million Investment in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised - Eastern Progress

Aug 07, 2026
pulisher
Aug 07, 2026

Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call High - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed? - Yahoo! Finance Canada

Aug 07, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call Highlights: Strong LINZESS Growth ... - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

IRWD Looks 15.8% Undervalued on GF Value™ as Debt Reduction Effo - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals Q2 Earnings Call Highlights - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:IRWD) 2026-08-06 - Seeking Alpha

Aug 06, 2026
pulisher
Aug 06, 2026

Is Ironwood Pharmaceuticals (IRWD) Undervalued After Q2 Earnings - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

IRWD: LINZESS sales surged and guidance was raised as apraglutide advanced in phase III trials - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026

Ironwood Pharmaceuticals Inc (IRWD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Ironwood Pharmaceuticals Inc (IRWD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
RONALD SILVER
Officer
Jul 07 '26
Proposed Sale
4.38
127,890
560,158
0
Silver Ronald
PFO & PAO
Jul 07 '26
Sale
4.52
127,890
578,063
313,680
McHugh Julie
Director
Jun 16 '26
Sale
3.73
21,571
80,460
250,749
JULIE MCHUGH
Director
Jun 16 '26
Proposed Sale
3.69
21,571
79,597
0
DENNER ALEXANDER J
Director
Mar 17 '26
Sale
3.05
6,730,800
20,530,448
9,188,635
MCCOURT Thomas A
Chief Executive Officer
Feb 24 '26
Sale
3.66
103,526
378,905
1,489,002
Silver Ronald
Principal Accounting Officer
Feb 24 '26
Sale
3.66
12,621
46,193
252,636
Gaskins Tammi L
Chief Commercial Officer
Feb 24 '26
Sale
3.66
11,239
41,135
213,738
Martini Gregory S.
Chief Financial Officer
Feb 24 '26
Sale
3.66
11,457
41,933
160,601
John Minardo
Chief Legal Officer
Feb 24 '26
Sale
3.66
19,053
69,734
363,886
EVO EVO
$1.52
price down icon 3.80%
$3.88
price down icon 3.96%
$7.35
price down icon 2.26%
$7.32
price down icon 9.52%
$7.6975
price down icon 3.18%
$23.75
price down icon 1.17%
大文字化:     |  ボリューム (24 時間):